Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending April 26, 2020 Dermatomyositis without dermatitis correlates with autoantibodies, ACEI/ARBs linked with survival in hypertensive, Chinese COVID-19 patients, More must reads Must reads for theWeek ending April 19, 2020 N.Y. universal testing: Many COVID-19+ pregnant women are asymptomatic, U.S. prevalence of antinuclear antibodies has steadily risen, study finds, Financial incentives affect the adoption of biosimilars, Severe COVID-19 may lower hemoglobin levels, Most e-consults not followed by specialist visit, More must readsMust reads for theWeek ending April 12, 2020 Cell therapy closes large wounds in epidermolysis bullosa, Dupilumab hits the mark for severe AD in younger children, Treatment for RA, SpA may not affect COVID-19 severity, JAK inhibitors may increase risk of herpes zoster, More must readsMust reads for theWeek ending April 5, 2020 Genome study examines heritability of psoriatic disease subtypes, Low-income DC communities have restricted access to iPLEDGE pharmacies, Rapid shift to adalimumab biosimilars in Denmark contrasts with U.S. experience, More must readsMust reads for theWeek ending March 29, 2020 Reports suggest possible in utero transmission of novel coronavirus 2019, Survey explores the role of social media in choosing a dermatologist, Study: Delays filling biologic prescriptions have consequences, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 last »
